• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study.伊朗 COVID-19 严重程度和死亡的相关风险因素:系统评价和荟萃分析研究。
J Intensive Care Med. 2023 Sep;38(9):825-837. doi: 10.1177/08850666231166344. Epub 2023 Mar 28.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
6
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
10
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.

引用本文的文献

1
Association between COVID-19 Mortality and Underlying Disease; Tehran, Iran.伊朗德黑兰:新冠病毒疾病死亡率与基础疾病之间的关联
J Caring Sci. 2024 Jun 2;14(1):37-41. doi: 10.34172/jcs.025.33254. eCollection 2025 Feb.
2
Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness.伊朗西北部COVID-19发病率和死亡率的空间分析,以做好未来疫情防范准备。
Sci Rep. 2025 Mar 3;15(1):7450. doi: 10.1038/s41598-025-91246-y.
3
Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE).追踪医院内新冠病毒感染的结果:多州模型探索(TRACE)
Life (Basel). 2024 Sep 21;14(9):1195. doi: 10.3390/life14091195.
4
Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia.2019年冠状病毒病疫情对血友病儿童及成人患者的影响。
Ann Hematol. 2025 Jan;104(1):95-104. doi: 10.1007/s00277-024-05992-6. Epub 2024 Sep 14.
5
The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients.五聚体蛋白3血清水平和血管紧张素转换酶多态性对COVID-19患者肺部浸润和死亡率的影响
Biomedicines. 2024 Jul 20;12(7):1618. doi: 10.3390/biomedicines12071618.
6
Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital.雅加达中央医院(Cipto Mangunkusumo National General Hospital)印度尼西亚住院COVID-19患者全因30天死亡率的相关因素
J Clin Med. 2024 May 20;13(10):2998. doi: 10.3390/jcm13102998.
7
Dietary mineral intakes predict Coronavirus-disease 2019 (COVID-19) incidence and hospitalization in older adults.膳食矿物质摄入量可预测老年人感染2019冠状病毒病(COVID-19)的发病率和住院率。
BMC Nutr. 2024 Mar 4;10(1):42. doi: 10.1186/s40795-024-00821-5.
8
The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19.序贯监测实验室指标和炎症生物标志物在评估新型冠状病毒肺炎严重程度中的作用
Cureus. 2024 Jan 1;16(1):e51458. doi: 10.7759/cureus.51458. eCollection 2024 Jan.
9
Analysis of death risk factors among COVID-19 patients in Yazd, Iran: A case-cohort study.伊朗亚兹德 COVID-19 患者死亡风险因素分析:病例对照研究。
J Prev Med Hyg. 2023 Nov 1;64(3):E304-E310. doi: 10.15167/2421-4248/jpmh2023.64.3.3098. eCollection 2023 Sep.

本文引用的文献

1
Analysis of death risk factors among COVID-19 patients in Yazd, Iran: A case-cohort study.伊朗亚兹德 COVID-19 患者死亡风险因素分析:病例对照研究。
J Prev Med Hyg. 2023 Nov 1;64(3):E304-E310. doi: 10.15167/2421-4248/jpmh2023.64.3.3098. eCollection 2023 Sep.
2
Non-Pharmacological Infection Prevention and Control Interventions in COVID-19: What Does the Current Evidence Say?2019冠状病毒病的非药物感染预防与控制干预措施:现有证据表明了什么?
Int J Prev Med. 2021 Dec 18;12:174. doi: 10.4103/ijpvm.IJPVM_604_20. eCollection 2021.
3
Death among patients hospitalized with symptomatic COVID-19: Implications for high-risk patients.COVID-19 有症状住院患者的死亡:高危患者的影响。
J Hosp Med. 2022 Apr;17(4):252-258. doi: 10.1002/jhm.12805. Epub 2022 Mar 16.
4
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines.新冠疫情背景下疫苗接种的重要性:关于疫苗使用的简要更新
Vaccines (Basel). 2022 Apr 12;10(4):591. doi: 10.3390/vaccines10040591.
5
Optimization of a new adaptive intervention using the SMART Design to increase COVID-19 testing among people at high risk in an urban community.利用 SMART 设计优化新的适应性干预措施,以增加城市社区高危人群的 COVID-19 检测。
Trials. 2022 Apr 14;23(1):310. doi: 10.1186/s13063-022-06216-w.
6
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019.1990 - 2019年欧洲年轻人的精神障碍、物质使用障碍和自我伤害负担:全球疾病负担研究2019的结果
Lancet Reg Health Eur. 2022 Apr 1;16:100341. doi: 10.1016/j.lanepe.2022.100341. eCollection 2022 May.
7
China can prepare to end its zero-COVID policy.中国可以准备结束其新冠疫情清零政策。
Nat Med. 2022 Jun;28(6):1104-1105. doi: 10.1038/s41591-022-01794-3.
8
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.估算2019冠状病毒病大流行造成的超额死亡率:2020 - 2021年与2019冠状病毒病相关死亡率的系统分析
Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10.
9
Association of vitamin D deficiency with COVID-19 severity and mortality in Iranian people: a prospective observational study.伊朗人群中维生素D缺乏与COVID-19严重程度及死亡率的关联:一项前瞻性观察性研究。
Acute Crit Care. 2021 Nov;36(4):300-307. doi: 10.4266/acc.2021.00605. Epub 2021 Nov 29.
10
Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran.合并症对COVID-19住院患者死亡率的影响:来自伊朗的经验。
J Educ Health Promot. 2021 Dec 31;10:460. doi: 10.4103/jehp.jehp_1589_20. eCollection 2021.

伊朗 COVID-19 严重程度和死亡的相关风险因素:系统评价和荟萃分析研究。

Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study.

机构信息

Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Intensive Care Med. 2023 Sep;38(9):825-837. doi: 10.1177/08850666231166344. Epub 2023 Mar 28.

DOI:10.1177/08850666231166344
PMID:36976873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10051011/
Abstract

This study aims to investigate the risk factors associated with severity and death from COVID-19 through a systematic review and meta-analysis of the published documents in Iran. A systematic search was performed based on all articles indexed in Scopus, Embase, Web of Science (WOS), PubMed, and Google Scholar in English and Scientific Information Database (SID) and Iranian Research Institute for Information Science and Technology (IRA)NDOC indexes in Persian. To assess quality, we used the Newcastle Ottawa Scale. Publication bias was assessed using Egger's tests. Forest plots were used for a graphical description of the results. We used HRs, and ORs reported for the association between risk factors and COVID-19 severity and death. Sixty-nine studies were included in the meta-analysis, of which 62 and 13 had assessed risk factors for death and severity, respectively. The results showed a significant association between death from COVID-19 and age, male gender, diabetes, hypertension, cardiovascular disease (CVD), cerebrovascular disease, chronic kidney disease (CKD), Headache, and Dyspnea. We observed a significant association between increased white blood cell (WBC), decreased Lymphocyte, increased blood urea nitrogen (BUN), increased creatinine, vitamin D deficiency, and death from COVID-19. There was only a significant relationship between CVD and disease severity. It is recommended that the predictive risk factors of COVID-19 severity and death mentioned in this study to be used for therapeutic and health interventions, to update clinical guidelines and determine patients' prognoses.

摘要

本研究旨在通过对伊朗已发表文献的系统评价和荟萃分析,调查与 COVID-19 严重程度和死亡相关的风险因素。我们在 Scopus、Embase、Web of Science (WOS)、PubMed 和 Google Scholar 等英文数据库以及 Scientific Information Database (SID) 和 Iranian Research Institute for Information Science and Technology (IRA)NDOC 等波斯文数据库中进行了全面检索。我们使用纽卡斯尔-渥太华量表评估质量。使用 Egger 检验评估发表偏倚。森林图用于结果的图形描述。我们使用报告的风险因素与 COVID-19 严重程度和死亡之间关联的 HR 和 OR。荟萃分析共纳入 69 项研究,其中 62 项和 13 项分别评估了死亡和严重程度的风险因素。结果表明,COVID-19 死亡与年龄、男性、糖尿病、高血压、心血管疾病 (CVD)、脑血管疾病、慢性肾脏病 (CKD)、头痛和呼吸困难显著相关。我们观察到白细胞增多 (WBC)、淋巴细胞减少、血尿素氮 (BUN) 升高、肌酐升高、维生素 D 缺乏与 COVID-19 死亡显著相关。只有 CVD 与疾病严重程度存在显著关系。建议将本研究中提到的 COVID-19 严重程度和死亡的预测风险因素用于治疗和健康干预,以更新临床指南并确定患者的预后。